FDA Warning Letter Cites Part 11 Requirements

Washington Drug Letter
KEYWORDS FDA / Warning
A A

The FDA will enforce the electronic records and signatures regulation even as the agency moves toward revising it, says an industry expert pointing to a recent warning letter citing 21 CFR Part 11 validation and control requirements.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00